Annual CFF
$108.89 M
+$99.27 M+1031.69%
31 December 2023
Summary:
Pacific Biosciences of California annual cash flow from financing activities is currently $108.89 million, with the most recent change of +$99.27 million (+1031.69%) on 31 December 2023. During the last 3 years, it has fallen by -$142.95 million (-56.76%). PACB annual CFF is now -90.69% below its all-time high of $1.17 billion, reached on 31 December 2021.PACB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$812.00 K
+$964.00 K+634.21%
30 September 2024
Summary:
Pacific Biosciences of California quarterly cash flow from financing activities is currently $812.00 thousand, with the most recent change of +$964.00 thousand (+634.21%) on 30 September 2024. Over the past year, it has increased by +$1.59 million (+203.97%). PACB quarterly CFF is now -99.91% below its all-time high of $865.72 million, reached on 31 March 2021.PACB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$74.39 M
+$1.59 M+2.10%
30 September 2024
Summary:
Pacific Biosciences of California TTM cash flow from financing activities is currently -$74.39 million, with the most recent change of +$1.59 million (+2.10%) on 30 September 2024. Over the past year, it has dropped by -$265.70 million (-138.88%). PACB TTM CFF is now -105.75% below its all-time high of $1.29 billion, reached on 30 September 2021.PACB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1031.7% | +204.0% | -138.9% |
| 3 y3 years | -56.8% | -99.7% | -105.8% |
| 5 y5 years | +1.6% | +148.3% | -643.1% |
PACB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -90.7% | +1031.7% | -99.7% | +101.0% | -105.8% | +7.6% |
| 5 y | 5 years | -90.7% | +1031.7% | -99.9% | +101.0% | -105.8% | +7.6% |
| alltime | all time | -90.7% | >+9999.0% | -99.9% | +101.0% | -105.8% | +7.6% |
Pacific Biosciences Of California Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $812.00 K(-634.2%) | -$74.39 M(-2.1%) |
| June 2024 | - | -$152.00 K(-102.3%) | -$75.98 M(-5.7%) |
| Mar 2024 | - | $6.55 M(-108.0%) | -$80.55 M(-174.0%) |
| Dec 2023 | $108.89 M(+1031.7%) | -$81.60 M(>+9900.0%) | $108.89 M(-43.1%) |
| Sept 2023 | - | -$781.00 K(-83.4%) | $191.31 M(-2.0%) |
| June 2023 | - | -$4.71 M(-102.4%) | $195.23 M(-2.6%) |
| Mar 2023 | - | $195.99 M(>+9900.0%) | $200.40 M(+1982.7%) |
| Dec 2022 | $9.62 M(-99.2%) | $819.00 K(-73.9%) | $9.62 M(-5.0%) |
| Sept 2022 | - | $3.13 M(+588.6%) | $10.13 M(-96.7%) |
| June 2022 | - | $455.00 K(-91.3%) | $306.65 M(-0.8%) |
| Mar 2022 | - | $5.21 M(+293.9%) | $309.07 M(-73.6%) |
| Dec 2021 | $1.17 B(+364.4%) | $1.32 M(-99.6%) | $1.17 B(-9.6%) |
| Sept 2021 | - | $299.66 M(>+9900.0%) | $1.29 B(+17.5%) |
| June 2021 | - | $2.88 M(-99.7%) | $1.10 B(+0.2%) |
| Mar 2021 | - | $865.72 M(+587.8%) | $1.10 B(+336.5%) |
| Dec 2020 | $251.84 M(+848.6%) | $125.88 M(+17.5%) | $251.84 M(+74.8%) |
| Sept 2020 | - | $107.14 M(>+9900.0%) | $144.09 M(+286.5%) |
| June 2020 | - | $628.00 K(-96.5%) | $37.28 M(-2.0%) |
| Mar 2020 | - | $18.20 M(+0.4%) | $38.06 M(+43.4%) |
| Dec 2019 | $26.55 M(-75.2%) | $18.13 M(+5444.6%) | $26.55 M(+93.8%) |
| Sept 2019 | - | $327.00 K(-76.6%) | $13.70 M(-82.9%) |
| June 2019 | - | $1.40 M(-79.1%) | $79.89 M(+1.9%) |
| Mar 2019 | - | $6.69 M(+26.7%) | $78.40 M(-26.9%) |
| Dec 2018 | $107.18 M(+55.8%) | $5.28 M(-92.1%) | $107.18 M(+5.1%) |
| Sept 2018 | - | $66.52 M(<-9900.0%) | $102.00 M(+169.2%) |
| June 2018 | - | -$94.00 K(-100.3%) | $37.88 M(-62.4%) |
| Mar 2018 | - | $35.47 M(>+9900.0%) | $100.87 M(+46.6%) |
| Dec 2017 | $68.81 M(+4.4%) | $96.00 K(-96.0%) | $68.81 M(-0.2%) |
| Sept 2017 | - | $2.41 M(-96.2%) | $68.91 M(-0.9%) |
| June 2017 | - | $62.90 M(+1745.6%) | $69.53 M(+76.6%) |
| Mar 2017 | - | $3.41 M(+1604.0%) | $39.38 M(-40.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $65.93 M(+80.8%) | $200.00 K(-93.4%) | $65.93 M(-30.8%) |
| Sept 2016 | - | $3.03 M(-90.8%) | $95.29 M(+0.6%) |
| June 2016 | - | $32.74 M(+9.3%) | $94.75 M(+48.1%) |
| Mar 2016 | - | $29.96 M(+1.3%) | $63.99 M(+75.5%) |
| Dec 2015 | $36.46 M(-13.2%) | $29.57 M(+1091.7%) | $36.46 M(+47.0%) |
| Sept 2015 | - | $2.48 M(+25.1%) | $24.80 M(+7.5%) |
| June 2015 | - | $1.98 M(-18.5%) | $23.07 M(+7.5%) |
| Mar 2015 | - | $2.43 M(-86.4%) | $21.47 M(-48.9%) |
| Dec 2014 | $41.99 M(-1.8%) | $17.90 M(+2287.2%) | $41.99 M(+72.0%) |
| Sept 2014 | - | $750.00 K(+97.4%) | $24.41 M(-2.8%) |
| June 2014 | - | $380.00 K(-98.3%) | $25.11 M(-30.4%) |
| Mar 2014 | - | $22.96 M(+7051.7%) | $36.07 M(-15.7%) |
| Dec 2013 | $42.77 M(+1481.2%) | $321.00 K(-77.8%) | $42.77 M(+0.8%) |
| Sept 2013 | - | $1.45 M(-87.2%) | $42.45 M(+1.8%) |
| June 2013 | - | $11.35 M(-61.7%) | $41.69 M(+36.2%) |
| Mar 2013 | - | $29.66 M(>+9900.0%) | $30.61 M(+1031.5%) |
| Dec 2012 | $2.71 M(-65.1%) | $2000.00(-99.7%) | $2.71 M(-8.6%) |
| Sept 2012 | - | $683.00 K(+157.7%) | $2.96 M(-51.6%) |
| June 2012 | - | $265.00 K(-84.9%) | $6.11 M(-33.3%) |
| Mar 2012 | - | $1.75 M(+582.9%) | $9.16 M(+18.4%) |
| Dec 2011 | $7.74 M(-97.6%) | $257.00 K(-93.3%) | $7.74 M(-96.5%) |
| Sept 2011 | - | $3.83 M(+15.6%) | $218.98 M(-2.1%) |
| June 2011 | - | $3.32 M(+896.4%) | $223.58 M(-29.9%) |
| Mar 2011 | - | $333.00 K(-99.8%) | $318.88 M(+0.1%) |
| Dec 2010 | $318.66 M(+375.5%) | $211.49 M(+2406.4%) | $318.66 M(+197.3%) |
| Sept 2010 | - | $8.44 M(-91.4%) | $107.17 M(+8.5%) |
| June 2010 | - | $98.62 M(>+9900.0%) | $98.73 M(>+9900.0%) |
| Mar 2010 | - | $116.00 K | $116.00 K |
| Dec 2009 | $67.01 M(-44.1%) | - | - |
| Dec 2008 | $119.93 M(<-9900.0%) | - | - |
| Dec 2007 | -$225.00 K | - | - |
FAQ
- What is Pacific Biosciences of California annual cash flow from financing activities?
- What is the all time high annual CFF for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual CFF year-on-year change?
- What is Pacific Biosciences of California quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly CFF year-on-year change?
- What is Pacific Biosciences of California TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM CFF year-on-year change?
What is Pacific Biosciences of California annual cash flow from financing activities?
The current annual CFF of PACB is $108.89 M
What is the all time high annual CFF for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual cash flow from financing activities is $1.17 B
What is Pacific Biosciences of California annual CFF year-on-year change?
Over the past year, PACB annual cash flow from financing activities has changed by +$99.27 M (+1031.69%)
What is Pacific Biosciences of California quarterly cash flow from financing activities?
The current quarterly CFF of PACB is $812.00 K
What is the all time high quarterly CFF for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly cash flow from financing activities is $865.72 M
What is Pacific Biosciences of California quarterly CFF year-on-year change?
Over the past year, PACB quarterly cash flow from financing activities has changed by +$1.59 M (+203.97%)
What is Pacific Biosciences of California TTM cash flow from financing activities?
The current TTM CFF of PACB is -$74.39 M
What is the all time high TTM CFF for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM cash flow from financing activities is $1.29 B
What is Pacific Biosciences of California TTM CFF year-on-year change?
Over the past year, PACB TTM cash flow from financing activities has changed by -$265.70 M (-138.88%)